Hofseth Biocare ASA (HOFBC.OL)
24 Feb 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-Hofseth Biocare Q4 operating loss narrows to NOK 18.5 million
- BRIEF-Hofseth Biocare Q3 EBITDA loss widens to NOK 41.2 mln
- BRIEF-Hofseth Biocare reports final results of Subsequent Offering
- BRIEF-Hofseth Biocare receives patent in the European Union
- BRIEF-Hofseth Biocare Q2 operating loss widens to NOK 47.5 million